169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
CD59 FOR INHIBITING INFLAMMASOME ACTIVATION
#1502Peanut formulations and uses thereof
#1503METHODS AND SYSTEMS FOR DETECTING TISSUE CONDITIONS
#1504PRECISION MEDICINE FOR PAIN: DIAGNOSTIC BIOMARKERS, PHARMACOGENOMICS, AND REPURPOSED DRUGS
#1505Methods for diagnosing bacterial vaginosis
#1506Macrophage stimulating 1 receptor (MST1R) variants and uses thereof
#1507Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan-Sulfate Mediated Macropinocytosis
#1508METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#1509Lectin Assay For Assessing Glycoforms As An Early Marker In Disease
#1510Non invasive process for the evaluation of the quality of internal dense connective tissues
#1511Methods for predicting risk of interstitial pneumonia
#1512BIOMARKERS FOR DIAGNOSIS OF LUNG DISEASES AND METHODS OF USE THEREOF
#1513CD137 binding fibronectin type III domains
#1514ICAM-1 MARKER AND APPLICATION THEREOF
#1515Diagnosis of Liver Pathology Through Assessment of Protein Glycosylation
#1516Screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios
#1517Mutations in rhodopsin gene in zebrafish and uses thereof
#1518GINGIVITIS DIAGNOSTIC METHODS, USES AND KITS
#1519BIOMARKERS FOR UROLOGIC CHRONIC PELVIC PAIN SYNDROME
#1520Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK
#1521METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
#1522COMPOSITIONS AND METHODS FOR DETERMINING GENETIC POLYMORPHISMS IN THE TMEM216 GENE
#1523METHOD FOR THE DIAGNOSIS OF C3NEF-MEDIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
#1524A METHOD FOR DIAGNOSING METABOLIC DISORDER
#1525BIOMARKER COMBINATION FOR IDENTIFICATION OF "AT-RISK" SUBJECTS FOR AKI
#1526METHOD OF PREDICTING AND DETERMINING THERAPEUTIC EFFECT ON RHEUMATOID ARTHRITIS DUE TO BIOLOGICAL FORMULATION
#1527Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity
#1528SYSTEMS AND METHODS TO DIAGNOSE SARCOIDOSIS AND IDENTIFY MARKERS OF THE CONDITION
#1529BAG3 as a target for therapy of heart failure
#1530COLON DISEASE TARGETS AND USES THEREOF
#1531METHODS AND SYSTEMS FOR BIOMARKER ANALYSIS
#1532IN VITRO METHOD FOR DETECTING INTESTINAL BARRIER FAILURE IN ANIMALS BY DETERMINING OVOTRANSFERRIN
#1533APPARATUS AND METHOD FOR ABSOLUTE QUANTIFICATION OF BIOMARKERS FOR SOLID TUMOR DIAGNOSIS
#1534Biomarkers of methotrexate-induced immune tolerance
#1535In vitro method for detecting intestinal barrier failure in animals
#1536Assay for the diagnosis of nematode infections
#1537Marker sequences for diagnosing and stratifying systemic sclerosis patients
#1538Methods of detecting and treating pulmonary hypertension
#1539Method for improving quality of therapeutic cell through real-time glutathione measurement
#1540METHOD OF IDENTIFYING LAUNDRY MALODOR, MOLDY MALODOR AND/OR SWEAT MALODOR MODULATING COMPOUNDS
#1541METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION
#1542DIAGNOSTIC FOR SJORGREN'S SYNDROME BASED ON A BIOMARKER
#1543QUANTITATIVE BIOMARKERS OF EHV-1 SUSCEPTIBILITY AND PROTECTION
#1544TISSUE MOLECULAR SIGNATURES OF KIDNEY TRANSPLANT REJECTIONS
#1545METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF APPENDICITIS AND DIFFERENTIATION OF CAUSES OF ABDOMINAL PAIN
#1546Biomarkers for Typing Allograft Recipients
#1547Nourin gene-based RNA molecular network: novel early diagnostic and prognostic biomarkers for coronary artery disease, unstable angina, STEMI/NSTEMI and heart failure
#1548METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE
#1549Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#1550SILICA NANOPARTICLES FOR BIOMARKER DIAGNOSIS AND METHOD FOR PRODUCING SAME
#1551Cyclocreatine phosphate: a novel bioenergetic therapy to prevent and treat ischemia-induced and aging-related cardiovascular and neurodegenerative diseases
#1552Diagnosis of asthma versus chronic obstructive pulmonary disease (COPD) using urine metabolomic analysis
#1553Evaluation, assays and treatment of pKal-mediated disorders
#1554ALLERGY ANTIGEN AND EPITOPE THEREOF
#1555MODULATION OF SPLENOCYTES IN CELL THERAPY
#1556Modifiers of CFTR-directed therapy
#1557ANTIBODY FOR DETECTING EARLY DAMAGE TO BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND USE THEREOF
#1558Method For Detecting Bodily Adhesions By Identifying Markers In Circulating Cells
#1559AGING CONDITION EVALUATION METHOD, INFORMATION PRESENTATION METHOD, AND SCREENING METHOD FOR SUBSTANCE THAT IMPROVES OR PREVENTS AGING CONDITION
#1560Identification and medical applications of anti-citrullinated-protein antibodies in rheumatoid arthritis
#1561Methods and systems for calibrating and using a camera for detecting an analyte in a sample
#1562Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases
#1563USE OF TETRASPANIN-2 FOR TREATING DIABETES AND SCREENING AN ANTI-DIABETIC AGENT
#1564Method for the early diagnosis of glaucoma
#1565Liver disease-related biomarkers and methods of use thereof
#1566Methods for determining DPP3 and therapeutic methods
#1567COMPANION DIAGNOSTIC FOR HTRA1 RNA ANTAGONISTS
#1568Method for determining the distinctive nutritional requirements of a patient
#1569RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
#1570Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof
#1571Novel CD47 Monoclonal Antibodies and Uses Thereof
#1572NANOCARRIERS AND THEIR PROCESSING FOR DIAGNOSTICS AND THERAPEUTICS
#1573BIOMARKERS FOR RISK PREDICTION OF MORTALITY
#1574Diagnosis and risk stratification of fungal infections
#1575METHOD FOR DETERMINING A TISSUE INJURY AND REPAIR (TIAR) PROCESS ASSOCIATED WITH ABNORMAL FORMATION OF ENDOMETRIAL TISSUE
#1576AUTOMATED IMMUNOANALYZER SYSTEM FOR PERFORMING DIAGNOSTIC ASSAYS FOR AUTOIMMUNE AND INFECTIOUS DISEASES
#1577CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
#1578Hydraulic instrument drive system for minimally invasive surgery
#1579PERIODONTAL DISEASE DIAGNOSTIC METHODS, USES AND KITS
#1580Methods for the diagnosis and treatment of endometriosis
#1581Device and method for detection of analytes
#1582Method for measuring quality of therapeutic cell through real-time glutathione measurement
#1583NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF
#15843-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#1585Method for the Diagnosis of Hereditary Angioedema
#1586Methods for treating diseases mediated by ERBB4-positive pro-inflammatory macrophages
#1587Minimally-invasive measurement of esophageal inflammation
#1588Systems and methods for diagnosing and treating chronic organ rejection
#1589Methods for prediction and early detection of diabetes
#1590Selenoprotein P for prediction of a first cardiovascular event
#1591Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
#1592PREDICTIVE BIOMARKERS FOR TREATMENT OF EYE DISEASES
#1593COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG FUNCTION
#1594Method for measuring a biomarker in a biological sample of an IPAF patient
#1595Delta-like ligand 1 for diagnosing severe infections
#1596METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#1597Use of leucine-zipper protein for diagnosis or treatment of fatty liver
#1598COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING LIVER DISEASES AND MONITORING TREATMENT OUTCOMES
#1599Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#1600INDUCTION OF SENESCENCE USING PROTON PUMP INHIBITORS
#16012-iminobiotin for use in the treatment of brain cell injury
#1602NT-proANP AND NT-proBNP FOR THE DIAGNOSIS OF STROKE
#1603METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS
#1604Highly Sensitive System and Method for Analysis of Troponin
#1605COMPOSITIONS AND METHODS FOR DETECTION OF DISEASES RELATED TO EXPOSURE TO INHALED CARCINOGENS
#1606Methods and compositions to enhance arteriogenesis
#1607METHOD FOR PREDICTING THE RISK OF A SUBJECT FOR CONTRACTING DIABETES MELLITUS AND/OR METABOLIC SYNDROME OR FOR DIAGNOSING METABOLIC SYNDROME IN A SUBJECT
#1608Bioengineered in vitro 3D model of human atherosclerotic plaque
#1609Treating Renal and Liver Dysfunction with TLR4 Antagonists
#1610DETECTION OF HORMONES IN HAIR SAMPLES AND OTHER BIOLOGICAL SAMPLES
#1611TREATING SCHIZOPHRENIA BASED ON A PANEL OF BIOMARKERS
#1612METHODS FOR DETECTING, ASSESSING SEVERITY AND TREATING MULTIPLE SCLEROSIS
#1613Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions
#1614GUT BACTERIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND METHODS THEREWITH IN DETECTING ILEAL FIBROSIS
#1615Anti-complement factor C1q Fab fragments and uses thereof
#1616PREDICTING SUICIDALITY USING A COMBINED GENOMIC AND CLINICAL RISK ASSESSMENT
#1617METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#1618BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS
#1619Methods for identifying and treating adrenomyeloneuropathy (AMN)
#1620HLA G-MODIFIED CELLS AND METHODS
#1621Antibody molecules to TIM-3 and uses thereof
#1622Circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protein 7 (IGFBP7) for the prediction of stroke
#1623METHOD FOR PREDICTING THE RISK OF GETTING A MAJOR ADVERSE CARDIAC EVENT
#1624Antibodies that specifically bind alpha klotho
#1625DIAGNOSIS OF CROHN'S DlSEASE AND ULCERATIVE COLITIS
#1626BIOMARKER OF PNPLA3 EXPRESSION
#1627PRO-ADM AS A THERAPY MONITORING MARKER FOR CRITCALLY ILL PATIENTS
#1628Machine assay and analysis for selecting antihypertensive drugs
#1629Peptides and method for treatment of cardiac arrest
#1630METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#1631Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients
#1632Prognosis and progression biomarkers for chronic kidney disease
#1633DEVICES AND METHODS FOR ISOLATING MATTERS OF INTEREST
#1634Biomarkers for joint ailments and uses thereof
#1635Method for the Diagnosis of Metachromatic Leukodystrophy
#1636Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
#1637Compositions and methods for diagnosing and treating peroxisomal diseases
#1638BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS
#1639DIRECT VISUALIZATION OF INTEGRATED STRESS RESPONSE ACTIVITY
#1640Anti-transthyretin antibodies
#1641METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
#1642IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
#1643IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
#1644IN-VITRO METHOD AND KIT FOR DIAGNOSING THE RISK OF SUFFERING FROM CARIES
#1645Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#1646Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#1647Methods for diagnosing and treating eosinophilic gastritis
#1648METHOD FOR GUIDANCE OF FLUID THERAPY BASED ON PROADRENOMEDULLIN
#1649PROADRENOMEDULLIN AS INDICATOR FOR RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS
#1650IDENTIFICATION AND MONITORING OF ACID HYDROLYSIS PRODUCTS OF IMMUNOGLOBULIN HEAVY CHAINS
#1651ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI
#1652Cystic fibrosis transmembrane conductance regulator gene mutations
#1653Treatment of severe community acquired pneumonia
#1654ALLERGY ANTIGEN AND EPITOPE FOR SAME
#1655METHOD OF PROGNOSIS
#1656URINARY TRACT INFECTION DIAGNOSTIC
#1657Mass spectrometry-based methods for the detection of circulating histones H3 and H2B in plasma from sepsis or septic shock (SS) patients
#1658Methods for assessing mucosal healing in Crohn's disease patients
#1659Therapeutic regimen for hypertension
#1660METHODS AND COMPOSITIONS FOR PREDICTING AND TREATING INTRACRANIAL ANEURYSM
#1661Method of treating acute coronary syndrome
#1662KIT FOR IN VITRO OR EX VIVO MEASUREMENT OF THE EXPRESSION OF sCD127 IN A BIOLOGICAL SAMPLE
#1663IMMUNOSIGNATURING: A PATH TO EARLY DIAGNOSIS AND HEALTH MONITORING
#1664Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#1665A Cell-Based Seeding Assay for Huntingtin Aggregation
#1666ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE
#1667Methods of detecting transthyretin
#1668ADJUSTED MULTI-BIOMARKER DISEASE ACTIVITY SCORE FOR INFLAMMATORY DISEASE ASSESSMENT
#1669Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status
#1670BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS
#1671METHODS OF TREATING GENETIC HEARING LOSS
#1672Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies
#1673ASSAYS FOR IGFBP7 HAVING IMPROVED PERFORMANCE IN BIOLOGICAL SAMPLES
#1674Devices and assays for diagnosis of viral and bacterial infections
#1675Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function
#1676Monitoring inflammation status
#1677METHOD FOR ESTIMATING THE EFFECTIVENESS AGAINST RHEUMATOID ARTHRITIS OF A T-LYMPHOCYTE CO-STIMULATION MODULATOR AGENT
#1678METHODS FOR MONITORING VEDOLIZUMAB TREATMENT
#1679COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISEASES OF THE LIVER
#1680BIOMARKERS IN EX VIVO LUNG PERFUSION (EVLP) PERFUSATE
#1681Pharmaceutical composition for prevention or treatment of heart failure
#1682Flavivirus peptide sequences, epitopes, and methods and uses thereof
#1683Methods of detecting osteoarthritis and predicting progression thereof
#1684Antibodies to human erythroferrone and uses thereof
#1685hGH Determination for Use to Guide Prevention of a Major Adverse Cardiac Event or a Cardiovascular Disease in a Subject
#1686COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISEASES OF THE LIVER
#1687MMP-8 AS A MARKER FOR IDENTIFYING INFECTIOUS DISEASE
#1688METHODS AND KITS FOR PREDICTING THE TRANSPLANTATION-FREE SURVIVAL TIME OF PATIENTS SUFFERING FROM CIRRHOSIS
#1689Methods utilizing D-dimer for diagnosis of periprosthetic joint infection
#1690Selection of agents modulating gastrointestinal pain
#1691Method of detecting TIM-3 using antibody molecules to TIM-3
#1692Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
#1693Biomarkers of organic acidemias
#1694Use of the extracellular domain of transferrin receptor 2 for the diagnosis and treatment of primary or secondary sclerosing diseases
#1695PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK
#1696BIOMARKERS FOR WOUND HEALING
#1697DEVELOPMENT OF MICROBIAL BIOSENSORS FOR INTESTINAL INFLAMMATION
#1698Early Diagnosis and Prognosis of Pre-Eclampsia
#1699METHODS FOR LARGE TISSUE LABELING, CLEARING AND IMAGING
#1700Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#1701Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#1702GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients
#1703Methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers
#1704Recombinant FSH composition for controlled ovarian stimulation
#1705MARKERS FOR DISEASE AND DISEASE EXTENT IN INFLAMMATORY BOWEL DISEASE
#1706Methods for diagnosing or predicting chronic bronchitis
#1707ALPHA-B CRYSTALLIN IN THE DIAGNOSIS OF NEONATAL BRAIN DAMAGE
#1708Anti-tenascin C antibodies and uses thereof
#1709Therapeutic agent for diseases associated with abnormalities in dystroglycan sugar chain modification and method for assaying associated enzyme
#1710Methods for diagnosis of type 1 diabetes
#1711Methods for detecting sinusoidal obstructive syndrome (SOS)
#1712A METHOD FOR DIAGNOSING OR MONITORING KIDNEY FUNCTION OR DIAGNOSING KIDNEY DYSFUNTION
#1713Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#1714Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease
#1715Treatment of circadian rhythm disorders
#1716MARKERS IN PREPUBERTY FOR CHILDHOOD-PREDIABETES
#1717METHODS FOR DIAGNOSIS OF EARLY STAGE HEART FAILURE
#1718Method for prediction of response to cardiovascular regeneration based on detecting the amount of biomarkers
#1719Diagnostics of periodontitis based on salivary HGF and MMP-8
#1720METHOD AND APPARATUS FOR DETERMINING INTERSTITIAL VOLUME
#1721COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#1722Trimethylamine compounds as risk predictors of cardiovascular disease
#1723THERAPEUTIC USES OF DULAGLUTIDE
#1724Saposin-A derived peptides and uses thereof
#1725EXTRACELLULAR VESICLE MARKERS FOR STABLE ANGINA AND UNSTABLE ANGINA
#1726Cardiovascular Risk Event Prediction and Uses Thereof
#1727Betaretrovirus epitopes and related methods of use
#1728COTL1 protein involved in maintaining homeostasis of hematopoietic stem cell, and use thereof
#172914-3-3 Antagonists for the Prevention and Treatment of Arthritis
#1730Image selection suggestions
#1731Biomarkers of renal injury
#1732DIAGNOSTIC ADVANCED GLYCATION END-PRODUCT ANTIBODIES
#1733Inflammasome activation in myelodysplastic syndromes
#1734Diagnosis and treatment of inflammatory bowel disease
#1735Detection of bioprosthetic valve degeneration
#17362-iminobiotin for use in the treatment of brain cell injury
#1737METHOD FOR DETERMINING VITAMIN B12 UPTAKE
#1738DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
#1739USE OF THE RHO GDP DISSOCIATION INHIBITOR 2 PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INTESTINAL INFLAMMATORY DISEASES
#1740METHOD AND KIT FOR DIAGNOSIS OF MUSCLE WEAKNESS-RELATED DISEASES USING BLOOD BIOMARKER
#1741Risk Assessment Tool for Patients with Sepsis
#1742Flattop (fltp) is a novel biomarker for beta cell maturation
#1743Methods for the diagnosis of fetal abnormalities
#1744Extreme ultraviolet radiation in genomic sequencing and other applications
#1745NOVEL CD47 MONOCLONAL ANTIBODIES AND USES THEREOF
#1746Anti-PD-L1 antibodies
#1747Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines
#1748Proteoliposome-based ZnT8 self-antigen for type 1 diabetes diagnosis
#1749SRM/MRM Assay for the Tumor Necrosis Factor Receptor Superfamily Member 8 (CD30) Protein
#1750METHODS AND ASSAYS RELATING TO THE TREATMENT OF INFECTION
#1751DESMOCOLLIN 1 INHIBITORS FOR THE PREVENTION OR TREATMENT OF ATHEROSCLEROSIS
#1752BIOMARKERS FOR LIVER FUNCTION
#1753Accurate, rapid and convenient single-step disease diagnostic method using self-amplification principle of detection signal
#1754MEASURING TRAIL BY LATERAL FLOW IMMUNOASSAY
#1755Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#1756Therapy for subarachnoid hemorrhage and ischemia
#1757Compositions and methods for neuralgenesis
#1758METHODS FOR DIAGNOSING AND TREATING CACHEXIA
#1759Multi-protein biomarker assay for brain injury detection and outcome
#1760DIAGNOSTICS OF GINGIVITIS BASED ON SALIVARY IL-1BETA AND HGF
#1761BIOMARKER COMBINATIONS FOR MONITORING CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND/OR ASSOCIATED MECHANISMS
#1762Methods for Diagnosing and Treating Subjects for Pulmonary Exacerbation
#1763Non-Glycosylated suPar Biomarkers and Uses Thereof
#1764Biosensor and application of the same
#1765TRANSCRIPTOMIC BIOMARKERS FOR INDIVIDUAL RISK ASSESSMENT IN NEW ONSET HEART FAILURE
#1766Use of engineered liver tissue constructs for modeling liver disorders
#1767DIAGNOSTIC METHODS, THERAPEUTIC AGENTS AND USES THEREOF
#1768DIAGNOSTIC AND THERAPEUTIC METHODS FOR IRAK4-MEDIATED DISORDERS AND CONDITIONS
#1769BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME
#1770SNX9 as a novel biomarker for chronic inflammation and associated immunosuppresion and a new regulator of T cell receptor expression and function
#1771Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#1772AFFINITY CAPTURE OF CIRCULATING BIOMARKERS
#1773Screening method
#1774BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#1775Methods for assessing treatment with a gastrointestinal implant
#1776Method for inhibiting calcification of a smooth muscle cell (SMC)
#1777Prevention of tissue ischemia and related methods
#1778LIPID BIOMARKERS FOR STABLE AND UNSTABLE HEART DISEASE
#1779METHOD, ARRAY AND USE FOR DETERMINING THE PRESENCE OF PANCREATIC CANCER
#1780Diagnostics of mild or advanced periodontitis based on salivary IL-1BETA and MMP-9
#1781METHOD TO DETERMINE IF A RETINA IS DAMAGED
#1782Kit for monitoring, detecting and staging GVHD
#1783Compositions and Methods to Detect Kidney Fibrosis
#1784MONOCLONAL ANTIBODIES TO HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 2 (HFGFR2) AND METHODS OF USE THEREOF
#1785Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof
#1786ProADM and/or histones as markers indicating an adverse event
#1787Methods and systems for diagnosing diseases
#1788Method for treating rheumatoid arthritis
#1789METHODS FOR SELECTING MEDICATIONS FOR TREATING PATIENTS HAVING ATTENTION-DEFICIT HYPERACTIVITY DISORDER
#1790ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF
#1791SYSTEM AND METHODS FOR DIAGNOSING ACUTE INTERSTITIAL NEPHRITIS
#1792METHODS OF DIAGNOSING DISEASES BY EXTRACELLULAR VESICLES AND USES THEREOF
#1793Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#1794ANIMAL MODEL OF A MOOD DISORDER AND SCREENING METHOD
#1795Combined use of FcγRIIb (CD32B) and CD20 specific antibodies
#1796Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#1797Use of IGFBP-7 in the assessment of heart failure
#1798METHOD FOR PROGNOSIS OF THE OUTCOME OF PATIENTS WITH HEART FAILURE (HF)
#1799USE OF SERUM 2-CYSTEINE PEROXIREDOXINS (2-CYS-PRDX) AS BIOMARKERS OF CHRONIC KIDNEY DISEASES
#1800Diagnostic markers for platelet function and methods of use